Skip to content

Alector, Inc.

ALEC

CIK 0001653087 · Biological Products, (No Diagnostic Substances) · Nasdaq

  • Alector LLC (until 2015-09-16)
← back to feed
Revenue (TTM)
$15.85M
−79.1% YoY Q1 May 2026
Net Income (TTM)
−$128.59M
−20.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.26
−13.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-891.6%
Q1 May 2026
Net Margin
-811.1%
Q1 May 2026
Free Cash Flow (TTM)
−$222.19M
Q1 May 2026
Cash
$76.96M
Q1 May 2026
Total Debt
$9.77M
Q1 May 2026
Shares Outstanding
111.03M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings